BULLA, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 9.621
EU - Europa 6.330
AS - Asia 2.136
SA - Sud America 43
AF - Africa 42
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 18.197
Nazione #
US - Stati Uniti d'America 9.578
PL - Polonia 1.308
IT - Italia 1.189
SE - Svezia 849
DE - Germania 776
CN - Cina 593
SG - Singapore 555
UA - Ucraina 524
RU - Federazione Russa 520
HK - Hong Kong 471
GB - Regno Unito 285
FI - Finlandia 183
TR - Turchia 155
IE - Irlanda 149
BG - Bulgaria 127
FR - Francia 106
VN - Vietnam 79
NL - Olanda 72
TW - Taiwan 58
BE - Belgio 50
CH - Svizzera 47
KR - Corea 46
JP - Giappone 38
IN - India 35
CA - Canada 34
AT - Austria 25
CZ - Repubblica Ceca 24
BR - Brasile 22
IR - Iran 21
SN - Senegal 21
PT - Portogallo 17
AE - Emirati Arabi Uniti 15
HU - Ungheria 13
ID - Indonesia 13
ES - Italia 12
AU - Australia 10
DK - Danimarca 10
CL - Cile 9
EU - Europa 8
MY - Malesia 8
LT - Lituania 6
MA - Marocco 6
MD - Moldavia 6
PH - Filippine 6
RO - Romania 6
IL - Israele 5
IQ - Iraq 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
SI - Slovenia 5
TH - Thailandia 5
ZA - Sudafrica 5
CO - Colombia 4
GR - Grecia 4
HR - Croazia 4
MX - Messico 4
NG - Nigeria 4
UZ - Uzbekistan 4
EC - Ecuador 3
EE - Estonia 3
KG - Kirghizistan 3
NO - Norvegia 3
PE - Perù 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BD - Bangladesh 2
EG - Egitto 2
GE - Georgia 2
LB - Libano 2
LV - Lettonia 2
RS - Serbia 2
SA - Arabia Saudita 2
AL - Albania 1
AN - Antille olandesi 1
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
PA - Panama 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 18.197
Città #
Warsaw 1.302
Fairfield 1.266
Woodbridge 1.081
Ann Arbor 881
Houston 751
Chandler 743
Ashburn 717
Wilmington 545
Seattle 511
Hong Kong 458
Trieste 452
Jacksonville 437
Cambridge 423
Singapore 386
Boardman 244
Princeton 228
Columbus 150
Beijing 135
Izmir 132
Moscow 128
Dublin 126
Sofia 125
Santa Clara 73
Dearborn 70
San Diego 69
Taipei 56
Dong Ket 49
Falls Church 49
Shanghai 49
Bern 43
Helsinki 41
Brussels 39
Seoul 39
Milan 38
Des Moines 31
Menlo Park 31
Redmond 31
Los Angeles 30
Munich 29
Redwood City 29
Saint Petersburg 26
Washington 26
Dallas 25
Nanjing 24
Guangzhou 23
Jinan 23
Dakar 21
Hefei 21
London 21
Arzene 20
Chicago 18
Toronto 18
Vienna 18
Duino-Aurisina 17
Kyiv 17
Bremen 16
Norwalk 16
Brno 15
Buffalo 15
Venice 15
Boydton 14
Kunming 14
Nuremberg 14
Udine 14
Cividale del Friuli 13
Fremont 13
Lappeenranta 13
Phoenix 13
Frankfurt am Main 12
Mestre 12
San Francisco 12
Tappahannock 12
Amsterdam 11
New York 11
Rome 11
Tokyo 11
Verona 11
Buon Ma Thuot 10
Sacile 10
Torino 10
Al Ain City 9
Budapest 9
Istanbul 9
Jakarta 9
Ottawa 9
Zhengzhou 9
Central 8
Dongguan 8
Düsseldorf 8
Hebei 8
Taiyuan 8
Venezia 8
West Jordan 8
Brescia 7
Monfalcone 7
Nanchang 7
Palermo 7
Shenyang 7
Sint-Genesius-Rode 7
Southend 7
Totale 12.812
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 709
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 414
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 404
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 350
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 296
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 272
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1 269
Pathological significance and prognostic value of surfactant protein D in cancer 254
Transcriptomics and immunological analyses reveal a pro-angiogenic and anti-inflammatory phenotype for decidual endothelial cells 249
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 236
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 231
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 230
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 224
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 222
Pre-eclampsia affects procalcitonin production in placental tissue 209
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 206
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 203
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 199
Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules 198
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 197
Analysis of anti-C1q antibodies in normal and pathological pregnancies 194
Placental trophoblast and endothelial cells as target of maternal immune response. 193
C1q is associated with a reduced inflammatory response of decidual endothelial cells 193
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 193
C1q is involved in human trophoblast invasion 193
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 186
Alternative functions of the complement protein C1q at embryo implantation site 178
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 175
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 168
Preeclampsia is associated with defective production of C1q by invasive trophoblast 167
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 166
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 164
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 164
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 164
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 162
null 161
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 161
null 159
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 157
null 155
null 154
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 152
null 151
Emerging Roles of the Complement System at Foeto-maternal Interface 149
null 148
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 147
C1q: A novel angiogenic factor? 146
Overview of procalcitonin in pregnancy and in pre-eclampsia 146
The complement system at the embryo implantation site 145
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 143
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 141
The Complement System at the Embryo Implantation Site: Friend or Foe? 138
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 136
null 136
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 134
Prevalence and biological effects of anti-trophoblast and anti-endothelial cell antibodies in patients with recurrent spontaneous abortions. 131
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 131
null 130
Surfactant protein D in immune surveillance against cancer 130
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 125
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 124
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 124
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 124
Prognostic Implications of the Complement Protein C1q in Gliomas 123
Human eosinophil peroxidase enhances tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages 122
null 121
Complement activation in animal and human pregnancies as a model for immunological recognition 121
null 121
null 119
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 118
Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions 116
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 115
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 114
Study of the prognostic significance of the protein C1q in carcinomas 113
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 112
null 110
null 109
”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco. 106
Feto-maternal immune interaction at the placental level 106
null 105
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 105
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 105
null 104
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 104
The mannose binding lectin pathway and early complement activation in (murine) abortion 104
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 104
null 103
null 101
null 101
Pathophysiology of the Complement System at Feto-Maternal Interface 101
The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis 97
[The maternal-fetal immune relationship in pregnancy] 96
null 94
Uterine immunity and microbiota: A shifting paradigm 93
Effect of a standardized liver and spleen fraction of peptides on the differentiation of human monocyte derived macrophages. 92
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 92
Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells 90
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 90
null 89
Inhibition of trophoblast adhesion to endothelial cells by the sera of women with recurrent spontaneous abortions. 85
Totale 16.111
Categoria #
all - tutte 53.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.567 0 0 0 0 0 0 0 369 412 296 316 174
2020/20212.755 248 193 258 380 229 294 216 227 167 255 96 192
2021/20221.910 66 119 138 123 77 174 113 86 241 191 136 446
2022/20232.437 233 329 179 354 219 409 32 211 278 34 109 50
2023/20241.847 149 100 154 119 160 204 311 270 58 75 137 110
2024/20251.827 81 129 284 268 334 349 251 131 0 0 0 0
Totale 18.868